Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 26-50 of 189 citing articles:

Exercise Inhibits Doxorubicin-Induced Cardiotoxicity via Regulating B Cells
Jing Wang, Shuqin Liu, Xinxiu Meng, et al.
Circulation Research (2024) Vol. 134, Iss. 5, pp. 550-568
Closed Access | Times Cited: 15
Pharmacological properties of Polygonatum and its active ingredients for the prevention and treatment of cardiovascular diseases
Hongyuan Lin, Wenhui Wang, Mengqi Peng, et al.
Chinese Medicine (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 14
Comparative versatility and diverse biological applications of eco-friendly zinc oxide and cobalt oxide nanoparticles using Punica granatum L. peel extract
Ahmed K. Saleh, Ahmed Saber Hussein, Julie Basu Ray, et al.
Nano-Structures & Nano-Objects (2024) Vol. 38, pp. 101174-101174
Closed Access | Times Cited: 9
Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms, Clinical Management and Innovative Treatment
Feiyu Gao, Tao Xu, F Zang, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 4089-4116
Open Access | Times Cited: 9
Managing Doxorubicin Cardiotoxicity: Insights Into Molecular Mechanisms and Protective Strategies
Adnan Taan Al khafaji, Ali Barakat, Akram Joudah shayyal, et al.
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 2
Closed Access | Times Cited: 1
Hollow mesoporous prussian blue nanozymes alleviate doxorubicin-induced cardiotoxicity by restraining oxidative stress associated with Nrf2 signaling
Fang Wang, Ke Wang, Baoru Fang, et al.
Journal of Colloid and Interface Science (2025) Vol. 686, pp. 1074-1088
Closed Access | Times Cited: 1
Sauchinone Preserves Cardiac Function in Doxorubicin-Induced Cardiomyopathy by Inhibiting the NLRP3 Inflammasome
Wei Xin, Hai Yang, Xinyu Heng, et al.
Phytomedicine (2025) Vol. 140, pp. 156624-156624
Open Access | Times Cited: 1
Dioscin protects against coronary heart disease by reducing oxidative stress and inflammation via Sirt1/Nrf2 and p38 MAPK pathways
Bo Yang, Bin Xu, Hua Zhao, et al.
Molecular Medicine Reports (2018)
Open Access | Times Cited: 83
The Role of Natural Products in Targeting Cardiovascular Diseases via Nrf2 Pathway: Novel Molecular Mechanisms and Therapeutic Approaches
Bee Kee Ooi, Kok‐Gan Chan, Bey‐Hing Goh, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 82
Targeting Reactive Oxygen Species in Cancer via Chinese Herbal Medicine
Qiaohong Qian, Wanqing Chen, Yajuan Cao, et al.
Oxidative Medicine and Cellular Longevity (2019) Vol. 2019, pp. 1-23
Open Access | Times Cited: 72
Nicorandil combats doxorubicin–induced nephrotoxicity via amendment of TLR4/P38 MAPK/NFκ-B signaling pathway
Ali Khames, Marwa M. Khalaf, Amany M. Gad, et al.
Chemico-Biological Interactions (2019) Vol. 311, pp. 108777-108777
Closed Access | Times Cited: 57
Toxic effects and molecular mechanism of doxorubicin on different organs – an update
Kaviyarasi Renu, Lakshmi Prasanna Pureti, Balachandar Vellingiri, et al.
Toxin Reviews (2021) Vol. 41, Iss. 2, pp. 650-674
Closed Access | Times Cited: 56
Resolvin E1 protects against doxorubicin-induced cardiotoxicity by inhibiting oxidative stress, autophagy and apoptosis by targeting AKT/mTOR signaling
Jishou Zhang, Menglong Wang, Wen Ding, et al.
Biochemical Pharmacology (2020) Vol. 180, pp. 114188-114188
Closed Access | Times Cited: 53
Dioscin and diosgenin: Insights into their potential protective effects in cardiac diseases
Xiaofen Li, Sili Liu, Liping Qu, et al.
Journal of Ethnopharmacology (2021) Vol. 274, pp. 114018-114018
Closed Access | Times Cited: 51
Exploring the role of ferroptosis in the doxorubicin-induced chronic cardiotoxicity using a murine model
Xiaofen Li, Jiyi Liang, Liping Qu, et al.
Chemico-Biological Interactions (2022) Vol. 363, pp. 110008-110008
Closed Access | Times Cited: 37
Calycosin Alleviates Doxorubicin-Induced Cardiotoxicity and Pyroptosis by Inhibiting NLRP3 Inflammasome Activation
Lei Zhang, Cundong Fan, Huachen Jiao, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 36
Multiple Roles of SIRT2 in Regulating Physiological and Pathological Signal Transduction
Changhui Zhu, Xue Dong, Xiwei Wang, et al.
Genetics Research (2022) Vol. 2022, pp. 1-14
Open Access | Times Cited: 35
Dioscin Protects against Cisplatin-Induced Acute Kidney Injury by Reducing Ferroptosis and Apoptosis through Activating Nrf2/HO-1 Signaling
Shuang Wang, Yingce Zheng, Shengzi Jin, et al.
Antioxidants (2022) Vol. 11, Iss. 12, pp. 2443-2443
Open Access | Times Cited: 34
Doxorubicin-mediated cardiac dysfunction: Revisiting molecular interactions, pharmacological compounds and (nano)theranostic platforms
Xiaofeng Li
Environmental Research (2023) Vol. 234, pp. 116504-116504
Closed Access | Times Cited: 20
Cinnamaldehyde alleviates doxorubicin-induced cardiotoxicity by decreasing oxidative stress and ferroptosis in cardiomyocytes
M. Mao, Zheng Wang, Bin Deng, et al.
PLoS ONE (2023) Vol. 18, Iss. 10, pp. e0292124-e0292124
Open Access | Times Cited: 20
Dioscin: Therapeutic potential for diabetes and complications
Haoyang Gao, Ze Wang, Danlin Zhu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 116051-116051
Open Access | Times Cited: 19
MicroRNA in the Diagnosis and Treatment of Doxorubicin-Induced Cardiotoxicity
Ziyu Kuang, Jingyuan Wu, Ying Tan, et al.
Biomolecules (2023) Vol. 13, Iss. 3, pp. 568-568
Open Access | Times Cited: 18
Novel pterostilbene derivatives ameliorate heart failure by reducing oxidative stress and inflammation through regulating Nrf2/NF-κB signaling pathway
Xiaoxiao Yang, Zhigang Liu, Mengyuan Fang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115602-115602
Closed Access | Times Cited: 18
Amelioratory effects of astragaloside IV on hepatocarcinogenesis via Nrf2-mediated pSmad3C/3L transformation
Yong Fang Gong, Shu Hou, Jiacheng Xu, et al.
Phytomedicine (2023) Vol. 117, pp. 154903-154903
Closed Access | Times Cited: 17
Dihydroartemisinin alleviates doxorubicin‐induced cardiotoxicity and ferroptosis by activating Nrf2 and regulating autophagy
Zhi-hui Lin, Huaqiang Xiang, Yongwei Yu, et al.
The FASEB Journal (2024) Vol. 38, Iss. 10
Closed Access | Times Cited: 8

Scroll to top